Seekyo: Funding, Investors & Team (Aug 2026)
Seekyo is a privately-owned biotech company that develops the next generation of chemotherapies By targeting the microenvironment of solid tumors while sparing healthy tissues, our aim is to provide treatments without adverse effects to cancer patients. Seekyo’s Smart Drugs transport potent anticancer agents in an innocuous manner toward safe tissues, provide efficient recognition of malignant specificities thanks to its targeting unit and allow the controlled release of the parent drug exclusively at the tumour site, based on its versatile enzyme-responsive self-immolative linker.
Seekyo has raised $800k across 1 funding round on record, the most recent a Seed of $800k announced in Mar 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Seekyo Company Profile and Key Stats
Latest funding round on record: Mar 2021.
Seekyo Funding Rounds
Seekyo Founders and Leadership Team
Contact details for the Seekyo team: 1 of 1 has an email address on file.
Start 14-day free trial →Seekyo Funding Compared to Other Biotechnology Startups
Seekyo's latest round of $800k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Seekyo in Biotechnology and Poitiers
Companies Similar to Seekyo
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
Seekyo Funding FAQs
What does Seekyo do?
Seekyo is a privately-owned biotech company that develops the next generation of chemotherapies By targeting the microenvironment of solid tumors while sparing healthy tissues, our aim is to provide treatments without adverse effects to cancer patients. Seekyo’s Smart Drugs transport potent anticancer agents in an innocuous manner toward safe tissues, provide efficient recognition of malignant specificities thanks to its targeting unit and allow the controlled release of the parent drug exclusively at the tumour site, based on its versatile enzyme-responsive self-immolative linker.
How much funding has Seekyo raised?
Seekyo has raised $800k across 1 round on record. The most recent is a Seed of $800k announced in Mar 2021.
When did Seekyo last raise funding?
Seekyo's most recent funding round on record is a Seed of $800k, announced in Mar 2021.
Who is the CEO of Seekyo?
Oury Chetboun is listed as CEO at Seekyo.
Where is Seekyo headquartered?
Seekyo is based in Poitiers, Poitou-Charentes, France.
How many employees does Seekyo have?
Seekyo is in the 1-10 employee band.
How does Seekyo's funding compare to other Biotechnology startups?
Seekyo's latest round of $800k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Seekyo Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Seekyo is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.